In this event, we focus on the Asia Pacific region, uncovering the landscape of animal welfare legislation and its implications for pharmaceutical and biotech players.
Gain insider insights from regional suppliers and delve into the specifics of Asia Pacific’s practices. This comprehensive overview aims to empower your organization to promote and uphold animal welfare without compromising ethical integrity or regulatory compliance.
Watch this comprehensive deep dive into animal welfare practices and legislation in the Asia Pacific region and gain valuable knowledge that could redefine your approach to animal welfare.
Presenters
Senior Director
In Vivo and GLP Services
Scientist.com
Meaghan Loy is currently the Senior Director of In Vivo and GLP Services at Scientist.com, a research marketplace that enables researchers to access pre-qualified assessed animal model suppliers as well as hundreds of suppliers that provide in vitro models that can potentially replace or reduce the use of in vivo models. She joined Scientist.com in 2018 and is an expert in the use of COMPLi®, Scientist.com’s award winning platform that introduces a common, comprehensive process and supply agreement supporting access to pre-qualified assessed suppliers of in vivo and in vitro research models and provides animal welfare compliance coverage.
Founder, President & CEO
Shanghai LIDE Co. Ltd. (LIDE)
Dr. Wen’s research foundation was 12 years at Millennium Pharmaceutical, Biogen-Idec in Boston, MA. In 2007, attracted by the innovation coming from overseas, she returned to China as VP of Biology at Shanghai ChemPartner. She founded Shanghai LIDE Biotech in 2011 to drive research and development in personalized precision medicine.
Additional Content From Scientist.com
Circulating Nucleosome Quantification (Nu.Q®) Technology for Monitoring Target Engagement and Adverse Events in Oncology Trials
Join us for a comprehensive webinar featuring experts in epigenetics and assay development, focusing on the scientific foundations and applications of Nucleosome Quantification (Nu.Q®) Technology in the realms of drug development and disease monitoring.
Innovative Approaches to Assessing Thyroid Disruption: The 3D Human Thyroid Microtissue Model
Dr. Chad Deisenroth, PhD, from the US EPA, introduces an advanced human in vitro 3D thyroid microtissue model designed to evaluate thyroid hormone disruption, addressing current challenges with existing models.
Discover the Freshness of Frozen PBMCs – An Assessment of Cryopreservation Impact on T Cell Activation and Phenotype
Discover the impact of cryopreservation of PBMCs on T cell activation and phenotype in Lonza’s free webinar.
Related Content
Let’s Get Physiological: Non-Invasive Intraoperative Monitoring Basics
This demo offers an introduction to some more common methods of monitoring, with a focus on offerings from Kent Scientific.
Getting to the Heart of Cardiovascular Research: From Yesterday to Today and Looking Towards Tomorrow
Dr. Melanie White presents the various methods for assessing cardiac function in the context of pathology, spanning from in vitro to in vivo techniques, and how she integrates these with cutting-edge mass spectrometry in her research on cardiovascular disease pathogenesis.
Unraveling European Animal Welfare Legislation for Biotech & Pharma
This event illuminates the intricacies of animal welfare legislation, specifically comparing and distinguishing differences between EU, UK, and North American standards.